INCB123667
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for INCB123667, covering 2026-01-07 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression [Phase 3]